Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)
Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF) is a paper indexed in PICO Portal from OpenAlex.
How many citations does Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF) have?
Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF) has 94 citations in the OpenAlex counts PICO Portal stores.
When was Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF) published?
Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF) has 2021 year in the PICO Portal index.
What is the open-access status of Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)?
Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF) has closed oa status in the PICO Portal index.
What is the DOI of Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)?
The DOI for Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF) is on the source record.
What is the PMID of Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)?
The PMID for Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF) is on the source record.
What is the OpenAlex record for Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF)?
The OpenAlex for Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF) is on the source record.